| Annual Financials | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Revenue  | 17 | 20 | 31 | 31 | 73 | 100 | 164 | 125 | 129 |
| Expenses | 17 | 20 | 31 | 31 | 71 | 98 | 161 | 122 | 124 |
| EBITDA | 0 | 0 | 0 | 0 | 2 | 2 | 3 | 3 | 5 |
| Operating Profit % | 0 % | 0 % | 0 % | 1 % | 3 % | 2 % | 2 % | 3 % | 4 % |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 2 | 2 | 1 |
| Profit Before Tax | 0 | 0 | 0 | 0 | 2 | 1 | 1 | 1 | 4 |
| Tax | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 1 |
| Net Profit | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 3 |
| EPS in ₹ | 17.27 | 9.15 | 16.86 | 6.91 | 333.39 | 0.76 | 0.45 | 0.41 | 1.00 |
Dipna Pharmachem
Dipna Pharmachem
5.63
-0.15
(-2.60%)
Market Cap
14.81 Cr
PE Ratio
5.78
Volume
1,83,000.00
Day High - Low
5.99 - 5.37
52W High-Low
25.50 - 5.35
Key Fundamentals
Market Cap
14.81 Cr
EPS
1.00
PE Ratio
5.78
PB Ratio
0.24
Book Value
23.70
EBITDA
4.99
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
2.53
Debt to Equity
0.48
Actual
Company News
View All News
Dipna Pharmachem FY26 net profit rises 170%
Jul 02, 2026
Jul 02, 2026Dipna Pharmachem reported a 170% YoY rise in net profit to ₹263.19 lakh for FY26. Revenue for the year stood at ₹1,291.09 crore.
Dipna Pharmachem director resignsJul 02, 2026
Jul 02, 2026Nandish Shaileshbhai Jani resigns as Independent Director of Dipna Pharmachem effective June 10, 2026, citing personal reasons.
Dipna Pharmachem accepts director resignationJul 02, 2026
Jul 02, 2026Parin Bhavsar resigned as Independent Director of Dipna Pharmachem Limited effective May 12, 2026, due to pre-occupancy. The company confirmed no other material reasons for the resignation.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,942.60 | #1 4,66,094.81 | 40.11 | #1 61,673.90 | 12.69 | #1 11,565 | 25.80 | 68.08 | |
7,188.50 | 1,90,832.09 | 71.68 | 10,560.00 | 8.73 | 2,520 | 13.44 | 71.13 | |
4,973.50 | 1,68,325.84 | 78.32 | 13,886.20 | 20.34 | 2,138 | -26.91 | 78.96 | |
1,438.10 | 1,16,176.23 | 29.85 | 29,044.60 | 2.24 | 3,870 | -55.32 | 55.29 | |
1,133.60 | 1,14,066.69 | 22.02 | 27,657.90 | 17.64 | 5,026 | 7.82 | 58.78 | |
2,469.20 | 1,12,899.86 | #1 21.32 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 62.48 | |
2,531.10 | 1,04,533.41 | 53.47 | 14,277.60 | 12.03 | 1,750 | 31.75 | 58.13 | |
1,246.20 | 1,04,016.46 | 24.79 | 35,058.60 | 3.90 | 4,158 | -86.05 | 37.29 | |
1,552.80 | 89,344.68 | 25.69 | 33,384.70 | 3.21 | 3,376 | 1.99 | 54.61 | |
1,560.70 | 84,255.42 | 94.51 | 6,867.80 | #1 22.01 | 890 | 21.18 | 67.15 |
Growth Rate
Revenue Growth
3.35 %
Net Income Growth
162.00 %
Cash Flow Change
-69.56 %
ROE
-12.46 %
ROCE
6.30 %
EBITDA Margin (Avg.)
40.22 %
Yearly Financial Results
Balance Sheet
| Balance Sheet | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 11 | 14 | 18 | 25 | 36 | 78 | 133 | 132 | 206 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 11 | 14 | 18 | 25 | 36 | 78 | 133 | 132 | 154 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 42 |
| Other Assets | 11 | 14 | 18 | 25 | 36 | 78 | 133 | 132 | 0 |
| Total Equity & Liabilities | 11 | 14 | 18 | 25 | 36 | 78 | 133 | 132 | 206 |
| Current Liabilities | 11 | 14 | 18 | 21 | 29 | 42 | 83 | 85 | 133 |
| Non Current Liabilities | 0 | 0 | 0 | 4 | 6 | 11 | 13 | 9 | 10 |
| Total Equity | 1 | 1 | 1 | 1 | 2 | 24 | 38 | 39 | 62 |
| Reserve & Surplus | 0 | 1 | 1 | 1 | 2 | 12 | 14 | 14 | 36 |
| Share Capital | 0 | 0 | 0 | 0 | 0 | 12 | 24 | 24 | 26 |
Cash Flow
| Cash Flow | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | 6 | 8 | -13 |
| Investing Activities | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Activities | -3 | -2 | 3 | -21 | -5 | -9 |
| Financing Activities | 3 | 3 | -3 | 27 | 14 | -4 |
Share Holding
| % Holding | Jul 2022 | Sept 2022 | Mar 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Sept 2024 | Mar 2025 | Sept 2025 | Nov 2025 | Mar 2026 |
| Promoter | 100.00 % | 66.56 % | 66.56 % | 57.19 % | 9.98 % | 9.98 % | 9.98 % | 9.98 % | 9.98 % | 9.13 % | 9.13 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 0.00 % | 31.32 % | 31.36 % | 40.33 % | 63.07 % | 63.07 % | 81.82 % | 71.21 % | 73.74 % | 79.11 % | 79.16 % |
| Others | 0.00 % | 2.12 % | 2.08 % | 2.48 % | 26.95 % | 26.95 % | 8.20 % | 18.81 % | 16.28 % | 11.76 % | 11.71 % |
| No of Share Holders | 7 | 1,178 | 992 | 1,078 | 1,807 | 1,807 | 2,652 | 1,997 | 1,742 | 1,741 | 1,717 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 03 Jan 2024 |  Extraordinary General Meeting | NA | 03 Jan 2024 | 10.02 | 8.92 |
| 12 Feb 2024 |  Rights | 13:12 | 12 Feb 2024 | 9.81 | 12.51 |
| 27 Aug 2024 |  Annual General Meeting | NA | 27 Aug 2024 | 7.73 | 8.89 |
| 11 Dec 2024 |  Quarterly Result Announcement | NA | 11 Dec 2024 | 7.74 | 7.74 |
| 04 Apr 2025 | Extraordinary General Meeting | NA | 04 Apr 2025 | 13.38 | 14.76 |
| 07 Jul 2025 | Quarterly Result Announcement | NA | 07 Jul 2025 | 23.28 | 24.13 |
| 30 Aug 2025 | Annual General Meeting | NA | 30 Aug 2025 | 20.20 | 19.00 |
| 26 Nov 2025 | Quarterly Result Announcement | NA | 26 Nov 2025 | 19.90 | 17.80 |
| 02 Jul 2026 | Quarterly Result Announcement | NA | 02 Jul 2026 | 7.20 | 6.50 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication8 days ago
8 days agoSubmission Of Integrated FinancialsJul 02, 2026
Jul 02, 2026Submission Of Statement Of Deviation And VariationJul 02, 2026
Jul 02, 2026Submission Of Financial ResultsJul 02, 2026
Jul 02, 2026Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. 2Nd July 2026Jul 02, 2026
Jul 02, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 02, 2026
Jul 02, 2026Announcement under Regulation 30 (LODR)-Resignation of DirectorJul 02, 2026
Jul 02, 2026Announcement under Regulation 30 (LODR)-Change in DirectorateJul 02, 2026
Jul 02, 2026Board Meeting Outcome for Outcome And Intimation Under Regulation 30 Of The SEBI (Listing Obligations And
Disclosure Requirements) Regulations 2015Jul 02, 2026
Jul 02, 2026Board Meeting Outcome for Outcome And Intimation For Rescheduling Of Board Meeting To 2Nd July 2026Jul 01, 2026
Jul 01, 2026Board Meeting Intimation for Outcome And Intimation For Rescheduling Of Board Meeting To 2Nd July 2026Jul 01, 2026
Jul 01, 2026Closure of Trading WindowJun 30, 2026
Jun 30, 2026Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Wednesday 1St July 2026Jun 27, 2026
Jun 27, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2026
May 30, 2026Voting Results For Postal BallotMay 25, 2026
May 25, 2026 Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 25, 2026
May 25, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 24, 2026
Apr 24, 2026Shareholder Meeting / Postal Ballot-Notice of Postal BallotApr 22, 2026
Apr 22, 2026Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 22, 2026
Apr 22, 2026Board Meeting Outcome for Outcome Of The Board Meeting And Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Apr 22, 2026
Apr 22, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2026
Apr 15, 2026Clarification Sought On Significant Movement In PriceApr 07, 2026
Apr 07, 2026Closure of Trading WindowMar 31, 2026
Mar 31, 2026Clarification sought from Dipna Pharmachem LtdFeb 23, 2026
Feb 23, 2026Announcement Under Regulation 30 (LODR)- Intimation Of Trading Approval Received For 2244000/- Equity Shares.Jan 21, 2026
Jan 21, 2026Clarification Sought On Significant Movement In PriceJan 21, 2026
Jan 21, 2026Clarification sought from Dipna Pharmachem LtdJan 14, 2026
Jan 14, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2026
Jan 07, 2026Announcement under Regulation 30 (LODR)-AllotmentNov 29, 2025
Nov 29, 2025Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Saturday 29Th November 2025Nov 29, 2025
Nov 29, 2025Statement Of Deviation And VariationNov 26, 2025
Nov 26, 2025Integrated Filing (Financial) For The Half Year Ended On 30Th September 2025Nov 26, 2025
Nov 26, 2025Unaudited Financial Results For The Half Year Ended On 30Th September 2025.Nov 26, 2025
Nov 26, 2025Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Wednesday 26Th November 2025Nov 26, 2025
Nov 26, 2025Announcement under Regulation 30 (LODR)-Resignation of DirectorNov 19, 2025
Nov 19, 2025Board Meeting Intimation for Intimation Of Rescheduling Of Board MeetingNov 19, 2025
Nov 19, 2025Board Meeting Intimation for Intimation Of Rescheduling Of Board MeetingNov 14, 2025
Nov 14, 2025Board Meeting Intimation for Intimation Of Board Meeting To Be Held On Friday 14Th November 2025Nov 10, 2025
Nov 10, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 10, 2025
Oct 10, 2025Closure of Trading WindowSep 30, 2025
Sep 30, 2025Board Meeting Outcome for Outcome Of Board MeetingSep 12, 2025
Sep 12, 2025Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E. Tuesday 9Th September 2025Sep 09, 2025
Sep 09, 2025Voting Results Of The Annual General MeetingSep 01, 2025
Sep 01, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportSep 01, 2025
Sep 01, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 30, 2025
Aug 30, 2025Intimation Of In-Principle Approval For Issue Of 76605000 Warrants Convertible Into Equity Shares Of M/S. Dipna Pharmachem Limited (The Company) Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligation And Disclosure RequiremeAug 30, 2025
Aug 30, 2025Undertaking Regarding Appointment Of Monitoring Agency - Preferential Issue Of Equity SharesAug 28, 2025
Aug 28, 2025Intimation Of Book Closure Pursuant To Regulation 42 Of The SEBI (Listing Obligation And Disclosure Requirement) Regulation 2015Aug 08, 2025
Aug 08, 2025Outcome Of Board Meeting & Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 08, 2025
Aug 08, 2025Reg. 34 (1) Annual Report.Aug 08, 2025
Aug 08, 2025Technical Indicators
RSI(14)
Neutral 36.64
ATR(14)
Less Volatile 0.57
STOCH(9,6)
Neutral 24.22
STOCH RSI(14)
Neutral 44.27
MACD(12,26)
Bearish -0.06
ADX(14)
Weak Trend 23.28
UO(9)
Bearish 50.21
ROC(12)
Downtrend And Accelerating -20.82
WillR(14)
Oversold -82.87
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
